<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7284148\results\search\disease\results.xml">
  <result pre="S. K. Maurya et al. MauryaSantosh K.aMauryaAkhilesh KumarbMishraNidhibhttp://orcid.org/0000-0001-8736-0487SiddiqueHifzur R.a[a], Molecular" exact="Cancer" post="Genetics &amp;amp; Translational Research Lab, Section of Genetics, Department"/>
  <result pre="of Information Technology AllahabadIndia CONTACT Hifzur R. Siddique hifzur.zo@amu.ac.inÂ Molecular" exact="Cancer" post="Genetics &amp;amp; Translational Research Laboratory, Section of Genetics, Department"/>
  <result pre="as a novel coronavirus (SARS-CoV-2) and found to trigger novel" exact="pneumonia" post="(COVID-19) in human beings and some other mammals. The"/>
  <result pre="pneumonia (COVID-19) in human beings and some other mammals. The" exact="uncontrolled" post="release of cytokines is seen from the primary stages"/>
  <result pre="mammals. The uncontrolled release of cytokines is seen from the" exact="primary" post="stages of symptoms to last acute respiratory distress syndrome"/>
  <result pre="is seen from the primary stages of symptoms to last" exact="acute" post="respiratory distress syndrome (ARDS). Thus, it is necessary to"/>
  <result pre="seen from the primary stages of symptoms to last acute" exact="respiratory" post="distress syndrome (ARDS). Thus, it is necessary to find"/>
  <result pre="the primary stages of symptoms to last acute respiratory distress" exact="syndrome" post="(ARDS). Thus, it is necessary to find out safe"/>
  <result pre="inti-infectious, and anti-protease compounds, which are attractive therapeutics to prevent" exact="infection" post="of the COVID-19. We found that top screened compound"/>
  <result pre="1. Introduction A new coronavirus, SARS-CoV-2, was found to cause" exact="pulmonary" post="disease in the city of Wuhan, China, in December"/>
  <result pre="Introduction A new coronavirus, SARS-CoV-2, was found to cause pulmonary" exact="disease" post="in the city of Wuhan, China, in December 2019"/>
  <result pre="its genomic RNA, which is about 82% similar to the" exact="Severe" post="Acute Respiratory Syndrome Coronavirus (SARS-CoV) [2]. These viruses are"/>
  <result pre="genomic RNA, which is about 82% similar to the Severe" exact="Acute" post="Respiratory Syndrome Coronavirus (SARS-CoV) [2]. These viruses are found"/>
  <result pre="RNA, which is about 82% similar to the Severe Acute" exact="Respiratory" post="Syndrome Coronavirus (SARS-CoV) [2]. These viruses are found to"/>
  <result pre="which is about 82% similar to the Severe Acute Respiratory" exact="Syndrome" post="Coronavirus (SARS-CoV) [2]. These viruses are found to link"/>
  <result pre="link with clade b of the Betacoronavirus genus [3]. The" exact="disease" post="caused by SARS-CoV-2 is known as coronavirus disease-19 (COVID-19)."/>
  <result pre="rate (https://www.worldometers.info/coronavirus). Coronaviruses (CoVs) have been found to affect the" exact="respiratory" post="tract and lead light to harsh respiratory tract infections"/>
  <result pre="to affect the respiratory tract and lead light to harsh" exact="respiratory" post="tract infections in humans [6]. In the past two"/>
  <result pre="the respiratory tract and lead light to harsh respiratory tract" exact="infections" post="in humans [6]. In the past two decades, the"/>
  <result pre="humans [6]. In the past two decades, the SARS-CoV (severe" exact="acute" post="respiratory syndrome-coronavirus) and the MERS-CoV (middle east respiratory syndrome-coronavirus)"/>
  <result pre="[6]. In the past two decades, the SARS-CoV (severe acute" exact="respiratory" post="syndrome-coronavirus) and the MERS-CoV (middle east respiratory syndrome-coronavirus) have"/>
  <result pre="SARS-CoV (severe acute respiratory syndrome-coronavirus) and the MERS-CoV (middle east" exact="respiratory" post="syndrome-coronavirus) have been found to emerge from animal reservoirs"/>
  <result pre="main protease enzyme could be an effective measure to check" exact="viral" post="replication [10]. Various forms of the viruses are found"/>
  <result pre="structure such as, m7GpppNm at the 5â€² end, which facilitate" exact="viral" post="duplication and help to escape recognition against innate immune"/>
  <result pre="in the interaction between NSP16 and NSP10 of SARS-CoV by" exact="short" post="peptides can inhibit the activity of 2â€²-O-MTase [13]. 2â€²-O-MTase"/>
  <result pre="of NSP16 methyltransferase activity by NSP10 is a common and" exact="primary" post="mechanism for the coronaviruses. It has been further demonstrated"/>
  <result pre="might use to find out specific anti-COVID-19 drugs to control" exact="infection" post="[11]. It was proved that the availability of FDA-approved"/>
  <result pre="patients and reduce the chances of the danger of the" exact="viral infection" post="caused by SARS CoV2. These drugs can tightly bind"/>
  <result pre="and reduce the chances of the danger of the viral" exact="infection" post="caused by SARS CoV2. These drugs can tightly bind"/>
  <result pre="the RdRp and thus may be useful to treat the" exact="disease" post="caused by the SARS CoV2. Furthermore, it has also"/>
  <result pre="vitamin B12, and nicotinamide may be helpful against COVID 19" exact="infections" post="[12]. Moreover, it has also been shown that the"/>
  <result pre="and Epclusa (Velpatasvir/Sofosbuvir) with their dual inhibitory actions on two" exact="viral" post="enzymes could be very effective [15]. The present study"/>
  <result pre="and tautomers were generated, using the OPLS-2005 force field. 2.2." exact="Protein" post="preparation The high-resolution structure of SARS-CoV2 main Protease (PDB"/>
  <result pre="Maestro 12.0 for the prediction of active binding sites. A" exact="total" post="of 4 binding sites was generated, and the top"/>
  <result pre="receptor grid generation module of maestro 12.0, i.e. 0.25 was" exact="partial" post="atomic charge and were 1.0â€‰Ã… was Van der Waals"/>
  <result pre="by keeping default parameters, i.e. scaling factor at 0.80 and" exact="partial" post="charge at 0.15. The binding affinity of docked ligands"/>
  <result pre="target proteins and may play a highly influencing against SARS-CoV-2" exact="infection" post="3.3. Estimation of binding-free energy MM/GBSA calculation was performed"/>
  <result pre="NSP10/NSP16 methyltransferase, which play a crucial role in inhibits the" exact="infection" post="of the virus of COVID 19 [10,11]. It has"/>
  <result pre="silico study may be an excellent agent to combat SARS-CoV-2" exact="infection" post="either alone or in combination. However, it warrants further"/>
  <result pre="conflict of interest. References References 1ZhouP, YangXL, WangXG, et al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="bat origin. Nature. 2020;579(7798):270â€&quot;273.32015507 2GorbalenyaAE, BakerSC, BaricRS, et al.The species" exact="Severe" post="acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it"/>
  <result pre="origin. Nature. 2020;579(7798):270â€&quot;273.32015507 2GorbalenyaAE, BakerSC, BaricRS, et al.The species Severe" exact="acute" post="respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2."/>
  <result pre="Nature. 2020;579(7798):270â€&quot;273.32015507 2GorbalenyaAE, BakerSC, BaricRS, et al.The species Severe acute" exact="respiratory" post="syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat"/>
  <result pre="modelling study. The Lancet. 2020;395(10225):689â€&quot;697. 4MackenzieJS, SmithDWCOVID-19: a novel zoonotic" exact="disease" post="caused by a coronavirus from China: what we know"/>
  <result pre="5WuF, ZhaoS, YuB, et al.A new coronavirus associated with human" exact="respiratory" post="disease in China. Nature. 2020; 579(7798):265â€&quot;269.32015508 6ZumlaA, ChanJF, AzharEI,"/>
  <result pre="ZhaoS, YuB, et al.A new coronavirus associated with human respiratory" exact="disease" post="in China. Nature. 2020; 579(7798):265â€&quot;269.32015508 6ZumlaA, ChanJF, AzharEI, et"/>
  <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="inÂ vitro. Cell Discov. 2020;6(1):1â€&quot;4.31934347 20PushpendraS, KushwahaPP, ShashankKNovel potent"/>
 </snippets>
</snippetsTree>
